Thalidomide to Treat Oral Lesions in HIV-Infected Patients - Related Studies

Thalidomide to Treat Oral Lesions in HIV-Infected Patients

This study has been completed.

Study NCT00001524. Last updated on March 3, 2008. Information provided by National Institutes of Health Clinical Center (CC)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Acquired Immunodeficiency Syndrome
		Burning Mouth Syndrome
		HIV Infection

2	Additional conditions recognized in this trial
		HIV Infections
		Immunologic Deficiency Syndromes
		Infection
		Syndrome

3	More general conditions related to this trial
		Disease
		Immune System Diseases
		Lentivirus Infections
		Mouth Diseases
		Pathologic Processes
		Retroviridae Infections
		RNA Virus Infections
		Sexually Transmitted Diseases
		Sexually Transmitted Diseases, Viral
		Slow Virus Diseases
		Stomatognathic Diseases
		Virus Diseases

4	Interventions listed in this trial
		Thalidomide

5	More general drug interventions related to this trial
		Angiogenesis Inhibitors
		Angiogenesis Modulating Agents
		Anti-Bacterial Agents
		Anti-Infective Agents
		Antineoplastic Agents
		Growth Inhibitors
		Growth Substances
		Immunologic Factors
		Immunosuppressive Agents
		Leprostatic Agents
		Pharmacologic Actions
		Physiological Effects of Drugs
		Therapeutic Uses

6	Sponsors listed in this trial
		National Institute of Dental and Craniofacial Research (NIDCR)